Unusual case of acute coronary syndrome: inferior wall myocardial infarction 19 years young male presented with fever and right ankle cellulites treated with tissue plasminogen activator and its out come
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20171124Keywords:
Tissue plasminogen activator, 19 years young myocardial infarctionAbstract
Unusual case of acute coronary syndrome: inferior wall myocardial infarction in 19yrs young male patient presented with fever and right ankle cellulites with fungal infection, thrombolysis was done with injection tenectaplase a newer tissue plasminogen activator with Troponin-T positive. Tenectaplase drug showed ECG changes within 30 minutes of thrombolysis with normal coronary during the angiography and preserved the left ventricular ejection function making it a successful thrombolysis by the tissue plasminogen activator (TPA) in young patient with myocardial infarction.
References
Yater WM, Traum AH, Brown WG, Fitzgerald RP, Geisler MA, Wilcox BB. Coronary artery disease in men 18 to 39 years of age. Am Heart J. 1948;36:334-8.
Jalowiec DA, Hill JA. Myocardial infarction in the young and in women. Cardiovascular Clini. 1989;20:197-206.
Cheitlin MD, McAllister LA, de Castro CM. Myocardial infarction without atherosclerosis. JAMA. 1975;231:951-9.
Welch GN, Loscalzo J. Homocystine and atherothrombosis. NEJM. 1998;338:1042-50.
Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma Homocystine levels and mortality in patients with coronary artery disease. NEJM. 1997;337:230-6.
Vaarala O. Antiphospholipid antibodies and atherosclerosis. Lupus. 19965:442-7.
Harats D, George J, Levy Y, Khamashta MA, Hughes GR, Shoenfeld Y. Atheroma: links with antiphospholipid antibodies, Hughes syndrome and lupus. Qjm. 1999;92(1):57-9.
Jouhikainen T, Pohjola-Sintonen S, Stephansson E. Lupus anticoagulant and cardiac manifestation in systemic lupus erythemetosus. Lupus. 1994;3:167.
Zimmerman FH, Cameron A, Fisher LD, Ng G. Myocardial infarction in young adults (angiographic characterization, risk factors and prognosis.(Coronary Artery Surgery Registry). J Am Col Cardiol. 1995;26:654-61.
Hamsten A, Wiman B, de Faire U, Blomback M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. NEJM. 1985;313:1557.
Chesler E, Matisonn RE, Lakier JB, Pocock WA, Obel, I.W., Barlow, J.B. Acute myocardial infarction with normal coronary arteries (a possible manifestation of the billowing mitral leaflet syndrome). Circulation. 1976;54:203-9.
Fournier JA, Sanchez-Gonzalez A, Quero J, Cortacero JA, Cabello A, Revello A, et al. Normal angiogram after myocardial infarction in young patients: A prospective clinical-angiographic and long-term follow-up study. Int J Cardiol. 1997;60(3):281-7.
Holmes DR, White HD, Pieper KS, Ellis SG, Califf RM, Topol EJ. Effect of age on outcome with primary angioplasty versus thrombolysis. J Am College of Cardiol. 1999;33(2):412-9.
